Table II.
Women without obesity (n = 21) | Women with obesity (n = 21) | Day fixed effect | Obesity fixed effect | |
---|---|---|---|---|
Follicular phase | ||||
AFC | 54 ± 28 | 50 ± 20 | P < 0.0001 | P = 0.671 |
AFC 2–5 mm | 48 ± 30 | 46 ± 20 | P < 0.0001 | P = 0.854 |
AFC 6–9 mm | 6 ± 4 | 4 ± 3 | P < 0.0001 | P = 0.056 |
Proportion 2–5 mm (%) | 86.0 ± 9.6 | 89.5 ± 8.5 | P < 0.0001 | P = 0.162 |
Proportion 6–9 mm (%) | 12.5 ± 9.4 | 9.0 ± 8.2 | P < 0.0001 | P = 0.139 |
Mean LH (mIU/ml) | 9.57 ± 12.66 | 9.68 ± 11.69 | P < 0.0001 | P = 0.727 |
Mean FSH (mIU/ml) | 6.76 ± 3.64 | 6.97 ± 3.50 | P = 0.158 | P = 0.845 |
Mean E2 (pg/ml) | 100.39 ± 9.75 | 103.73 ± 88.45 | P < 0.0001 | P = 0.887 |
Mean P4 (ng/ml) | 0.85 ± 1.41 | 0.41 ± 0.32 | P < 0.0001 | P = 0.027 |
Luteal phase | ||||
AFC | 59 ± 21 | 47 ± 19 | P = 0.974 | P = 0.559 |
AFC 2–5 mm | 45 ± 22 | 45 ± 19 | P = 0.274 | P = 0.764 |
AFC 6–9 mm | 4 ± 4 | 2 ± 2 | P < 0.0001 | P = 0.006 |
Proportion 2–5 mm (%) | 90.9 ± 8.5 | 95.0 ± 5.0 | P < 0.0001 | P = 0.008 |
Proportion 6–9 mm (%) | 8.9 ± 8.5 | 5.0 ± 5.0 | P < 0.0001 | P = 0.010 |
Mean LH (mIU/ml) | 5.84 ± 6.44 | 6.27 ± 6.02 | P < 0.0001 | P = 0.770 |
Mean FSH (mIU/ml) | 4.11 ± 2.61 | 3.93 ± 2.56 | P < 0.0001 | P = 0.637 |
Mean E2 (pg/ml) | 115.59 ± 57.51 | 116.33 ± 5.00 | P < 0.0001 | P = 0.727 |
Mean P4 (ng/ml) | 7.85 ± 5.74 | 4.95 ± 3.34 | P < 0.0001 | P = 0.001 |
Data are presented as mean ± SD. Groups were contrasted using generalized linear mixed models.
AFC, antral follicle count; E2, estradiol; P4, progesterone.